A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : T/N

Search Conditions:
Search Keyword : T/N
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: T/N
Appearance Frequency: 131 time(s)
Long forms: 44

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
tumor/normal
(29 times)
Neoplasms
(19 times)
NSCLC (5 times)
RT-PCR (5 times)
DPD (2 times)
1993 Gastric and hepatocellular carcinomas do not overexpress the same ribosomal protein messenger RNAs as colonic carcinoma.
tumor-to-normal tissue
(21 times)
Nuclear Medicine
(13 times)
ROC (3 times)
ASL (2 times)
DOPA (2 times)
1992 Non-invasive assessment of human tumour hypoxia with 123I-iodoazomycin arabinoside: preliminary report of a clinical study.
tumor-to-normal
(15 times)
Nuclear Medicine
(7 times)
OS (2 times)
pCR (2 times)
PET (2 times)
1998 Comparative study of technetium-99m-sestamibi and thallium-201 SPECT in predicting chemotherapeutic response in small cell lung cancer.
tumor/non-tumor
(8 times)
Gastroenterology
(2 times)
HCC (4 times)
ARC (1 time)
ccRCC (1 time)
1996 [The study of radioimmunoimaging on the nude mice bearing human ovarian carcinoma by labelling monoclonal antibody with 99mTc].
tumor-to-nontumor
(7 times)
Nuclear Medicine
(5 times)
201Tl (1 time)
AFP (1 time)
CYLD (1 time)
2003 Preliminary evaluation of image reconstruction by ordered-subset expectation maximization in thallium-201 lung scintigraphy.
tumour-to-normal cortex
(6 times)
Nuclear Medicine
(2 times)
Met (2 times)
ASL (1 time)
BEV (1 time)
2003 Gliomatosis cerebri evaluated by 18Falpha-methyl tyrosine positron-emission tomography.
tumor-to-contralateral normal brain tissue
(3 times)
Diagnostic Imaging
(2 times)
Met (2 times)
SUV (2 times)
CNS (1 time)
2011 Comparison of 11C-methionine PET and 18F-FDG PET in patients with primary central nervous system lymphoma.
tar and nicotine
(2 times)
Public Health
(1 time)
EEG (1 time)
1979 Changes in the cigarette consumption of smokers in relation to changes in tar/nicotine content of cigarettes smoked.
target/non-target
(2 times)
Medicine
(1 time)
CT (1 time)
NCT (1 time)
PET (1 time)
2008 The clinical usefulness of (99m)Tc-Tetrofosmin scintigraphy in the diagnosis of lung neoplasmas and mediastinal lymphoid node involvement.
10  tumor-to-background
(2 times)
Nuclear Medicine
(1 time)
IDH1-R132H (1 time)
MET (1 time)
SPECT (1 time)
2008 (123)I-Interleukin-2 uptake in squamous cell carcinoma of the head and neck carcinoma.
11  tumor-to-normal liver
(2 times)
Nuclear Medicine
(2 times)
CC (1 time)
DAB (1 time)
F-18 FDG PET (1 time)
2011 The value of F-18 FDG PET in patients with primary sclerosing cholangitis and cholangiocarcinoma using visual and semiquantitative analysis.
12  tumor/normal brain
(2 times)
Neurosurgery
(1 time)
FDG (1 time)
Met (1 time)
PET (1 time)
1997 Boron neutron capture therapy: preliminary study of BNCT with sodium borocaptate (Na2B1 2H1 1SH) on glioblastoma.
13  (Tc-T/N) and those of tumor to normal brain count
(1 time)
Nuclear Medicine
(1 time)
CE-MRI (1 time)
CECT (1 time)
2003 Extraosseous accumulation of bone scanning agents in malignant brain tumors: comparison to semi-quantitative evaluation with 99mTc SPECT/201Tl SPECT and histological findings.
14  T and N
(1 time)
Veterinary Medicine
(1 time)
CTCCs (1 time)
GLUT1 (1 time)
MCT-1 (1 time)
2016 Histological and immunohistochemical evaluation of stroma variations and their correlation with the Ki-67 index and expressions of glucose transporter 1 and monocarboxylate transporter 1 in canine thyroid C-cell carcinomas.
15  tar/nicotine
(1 time)
Neurology
(1 time)
EEG (1 time)
1989 Brain electrical imaging the dose-response effects of cigarette smoking.
16  technology was adopted to calculate target and non-target
(1 time)
Clinical Laboratory Techniques
(1 time)
18F-FDG (1 time)
LSCC (1 time)
PET (1 time)
2013 Application of clinical PET imaging to human laryngeal squamous cell carcinoma xenografts.
17  temporal to the nasal quadrant
(1 time)
Ophthalmology
(1 time)
I/N (1 time)
I/T (1 time)
N/T (1 time)
1998 [Relationship between visual field loss and retinal nerve fiber layer thickness in open-angle glaucoma].
18  theca-to-nucleus
(1 time)
Anatomy
(1 time)
PAS (1 time)
1979 A morphometric study quantifying the mucus content of proliferating colonic epithelial cells.
19  thrombotic/neurological
(1 time)
Rheumatology
(1 time)
aCL (1 time)
anti-beta2GPI (1 time)
anti-ProT (1 time)
1998 Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome.
20  thymidine followed by nocodazole
(1 time)
Cell Biology
(1 time)
FACS (1 time)
GPX1 (1 time)
Prx1 (1 time)
2019 Association of Gpx1 fluctuation in cell cycle progression.
21  time-dependent differences in drug concentration between tumor and normal
(1 time)
Biochemistry
(1 time)
ALA (1 time)
PpIX (1 time)
2000 Photodetection with 5-Aminolevulinic acid-induced protoporphyrin IX in the rat abdominal cavity: drug-dose-dependent fluorescence kinetics.
22  tissue sample and normal myocardium
(1 time)
Nuclear Medicine
(1 time)
--- 1980 Ischemia and infarction in the isolated rabbit heart: a model for the evaluation of myocardial imaging agents.
23  tissues/non-cancerous tissues OPRT expression
(1 time)
Medicine
(1 time)
DPD (1 time)
OPRT (1 time)
TS (1 time)
2005 [Expression of metabolic enzymes of fluoropyrimidines in primary colorectal cancer and its clinical significance].
24  transplant heart to native heart
(1 time)
Nuclear Medicine
(1 time)
allo (1 time)
Syn (1 time)
Tc-99m (1 time)
1990 Assessment of the dynamics of allograft rejection utilizing Tc-99m labeled lymphocytes.
25  tumor and normal liver parenchyma
(1 time)
Neoplasms
(1 time)
CECT (1 time)
SUVs (1 time)
2007 Optimization of FDG-PET/CT imaging protocol for evaluation of patients with primary and metastatic liver disease.
26  tumor and paired normal
(1 time)
Neoplasms
(1 time)
G3PDH (1 time)
HCC (1 time)
1998 Glyceraldehyde-3-phosphate dehydrogenase mRNA expression in hepatocellular carcinoma.
27  tumor delineation and greater tumor to non-tumor
(1 time)
Nuclear Medicine
(1 time)
201Tl (1 time)
FBP (1 time)
OSEM (1 time)
2003 Preliminary evaluation of image reconstruction by ordered-subset expectation maximization in thallium-201 lung scintigraphy.
28  tumor to contralateral normal gray matter
(1 time)
Diagnostic Imaging
(1 time)
ACE (1 time)
FDG (1 time)
Met (1 time)
2008 11C-acetate PET in the evaluation of brain glioma: comparison with 11C-methionine and 18F-FDG-PET.
29  tumor to normal uptake
(1 time)
Neoplasms
(1 time)
PET (1 time)
2018 Stereotactic image-based histological analysis reveals a correlation between 11C-methionine uptake and MGMT promoter methylation in non-enhancing gliomas.
30  tumor uptake to normal hemispheric tissue uptake
(1 time)
Nuclear Medicine
(1 time)
T/S (1 time)
2006 18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy.
31  tumor-to-nonmalignant
(1 time)
Neoplasms
(1 time)
5-FU (1 time)
2005 Variance in the expression of 5-Fluorouracil pathway genes in colorectal cancer.
32  tumor-to-normal contralateral cortex activity
(1 time)
Biology
(1 time)
FDG (1 time)
PCNSLs (1 time)
2019 Quantitative and Visual Characteristics of Primary Central Nervous System Lymphoma on 18F-FDG-PET.
33  Tumor-to-normal cortex count
(1 time)
Nuclear Medicine
(1 time)
FDG (1 time)
SUV (1 time)
T/W (1 time)
1999 18F alpha-methyl tyrosine PET studies in patients with brain tumors.
34  tumor-to-normal grey matter SUVmax rate
(1 time)
Nuclear Medicine
(1 time)
--- 2011 [Dual time point 18F-FDOPA PET as a tool for characterizing brain tumors].
35  tumor-to-normal hemispheric tissue
(1 time)
Neoplasms
(1 time)
SUV (1 time)
2013 Biopsy validation of 18F-DOPA PET and biodistribution in gliomas for neurosurgical planning and radiotherapy target delineation: results of a prospective pilot study.
36  tumor-to-normal liver tissue
(1 time)
Nuclear Medicine
(1 time)
CT (1 time)
FDG (1 time)
HCC (1 time)
2017 Does dual-time-point 18F-FDG PET/CT scan add in the diagnosis of hepatocellular carcinoma?
37  tumor-to-normal tissue count density
(1 time)
Brain
(1 time)
GBM (1 time)
PCNSL (1 time)
PET (1 time)
2013 [Usefulness and limitation of FDG-PET in the diagnosis of primary central nervous system lymphoma].
38  tumor-to-normal tissue tracer value
(1 time)
Therapeutics
(1 time)
CT (1 time)
2013 The usefulness of combined diagnostic CT and (99m)Tc-octreotide somatostatin receptor SPECT/CT imaging on pulmonary nodule characterization in patients.
39  tumor-to-normal tissue uptake
(1 time)
Nuclear Medicine
(1 time)
PET (1 time)
T/B (1 time)
2015 Comparison of 4'-[methyl-(11)C]thiothymidine ((11)C-4DST) and 3'-deoxy-3'-[(18)F]fluorothymidine ((18)F-FLT) PET/CT in human brain glioma imaging.
40  tumor/contralateral normal cortex
(1 time)
Neoplasms
(1 time)
ADC (1 time)
DWI (1 time)
FLAIR (1 time)
2019 Multimodal imaging-defined subregions in newly diagnosed glioblastoma: impact on overall survival.
41  tumor/mean SUV of normal cortex
(1 time)
Neurosurgery
(1 time)
AAs (1 time)
AOs (1 time)
CHO (1 time)
2019 Usefulness of positron emission tomography for differentiating gliomas according to the 2016 World Health Organization classification of tumors of the central nervous system.
42  tumor/node
(1 time)
Neoplasms
(1 time)
--- 2019 Preoperative Volumetric Modulated Arc Therapy With Simultaneous Integrated Boost for Locally Advanced Distal Rectal Cancer.
43  tumor/normal mucosa
(1 time)
Neoplasms
(1 time)
CRC (1 time)
MMP (1 time)
1996 Prediction of colorectal cancer relapse and survival via tissue RNA levels of matrix metalloproteinase-9.
44  Tumour-to-normal tissue background
(1 time)
Nuclear Medicine
(1 time)
CT (1 time)
SCCHN (1 time)
SPECT (1 time)
2001 99Tc(m) labelled HL91 versus computed tomography and biopsy for the visualization of tumour recurrence of squamous head and neck carcinoma.